Zeen Wu
Impact in
-
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics
- Microfluidic and Bio-sensing Technologies
- 3D Printing in Biomedical Research
Papers in
- Oncology 7
- Cancer Cells and Metastasis 7
-
- Microfluidic and Bio-sensing Technologies 4
- 3D Printing in Biomedical Research 3
- Nanoplatforms for cancer theranostics 1
- Co-authors
- Renjun Pei (11 shared papers)Zhili Wang (10 shared papers)Pi Ding (9 shared papers)Na Sun (8 shared papers)Lifen Liu (4 shared papers)Weipei Zhu (2 shared papers)Weipei Zhu (3 shared papers)Xue Cai (2 shared papers)
- Journals
- Journal of Materials Chemistry B (4 papers)Colloids and Surfaces B Biointerfaces (2 papers)ACS Applied Materials & Interfaces (2 papers)Materials Science and Engineering C (1 paper)Biosensors (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Zeen Wu
12 papers receiving 396 citations
Peers
Comparison fields: 5 of 58
- Biomaterials 79
- Biomedical Engineering 258
- Oncology 129
- Cancer Research 56
- Surfaces, Coatings and Films 16
Countries citing papers authored by Zeen Wu
This map shows the geographic impact of Zeen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeen Wu more than expected).
Fields of papers citing papers by Zeen Wu
This network shows the impact of papers produced by Zeen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeen Wu. The network helps show where Zeen Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Zeen Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 53 | |
| 2 | 2020 | 50 | |
| 3 | 2021 | 44 | |
| 4 | 2020 | 44 | |
| 5 | 2021 | 37 | |
| 6 | 2020 | 32 | |
| 7 | 2020 | 31 | |
| 8 | 2020 | 30 | |
| 9 | 2020 | 26 | |
| 10 | 2021 | 20 | |
| 11 | 2022 | 20 | |
| 12 | 2021 | 11 |
About Zeen Wu
Zeen Wu is a scholar working on Oncology, Biomedical Engineering, Molecular Biology, Biomaterials and Surgery, having authored 12 papers that have together received 398 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (7 papers), Advanced biosensing and bioanalysis techniques (5 papers), Microfluidic and Bio-sensing Technologies (4 papers), 3D Printing in Biomedical Research (3 papers), Cancer Genomics and Diagnostics (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Nanoplatforms for cancer theranostics (1 paper) and Surgical Sutures and Adhesives (1 paper). The work is most often cited by research in Biomaterials (79 citations), Biomedical Engineering (258 citations), Oncology (129 citations), Cancer Research (56 citations) and Surfaces, Coatings and Films (16 citations). Zeen Wu has collaborated with scholars based in China, United States and France. Frequent co-authors include Renjun Pei, Zhili Wang, Pi Ding, Na Sun, Lifen Liu, Weipei Zhu, Weipei Zhu, Xue Cai, Chungen Xing and Youxin Zhou. Their work appears in journals such as Journal of Materials Chemistry B, Colloids and Surfaces B Biointerfaces, ACS Applied Materials & Interfaces, Materials Science and Engineering C and Biosensors.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.